Literature DB >> 2322470

Crohn's disease in the Japanese is associated with the HLA-DRw53.

K Kobayashi1, M Atoh, A Yagita, Y Konoeda, H Inoko, A Ando, S Sekiguchi.   

Abstract

The association of Crohn's disease (CD) with the HLA system was investigated in Japanese patients by serological and genomic methods. HLA antigens were typed in 30 unrelated Japanese patients with CD and 54 healthy controls. The frequencies of HLA-DR4, DRw53 and DQw3 antigens were increased in CD (76.7, 86.7 and 80.0%) compared with controls [37.0%, p corrected (pc) = 0.007; 52.9%, pc = 0.001; 52.0%, pc = 0.009]. DQw7 and DQw8 antigens, the new split antigens of DQw3 produced by the TA10 antibody and linked to the DR4 and DRw53 antigens, were not significantly different in the DQw3-positive CD and controls. Class I antigens were not significantly different in the CD and controls. HLA-DR-B and DQ-B probes were used to study PstI-generated restriction fragment length polymorphism (RFLP) in CD and controls. The DRw53-specific PstI DR-B 2.6-kb fragment was increased in CD (88.0%) compared with controls (37.5%, pc = 5.6 X 10(-4)). The PstI DR-B 3.2-kb fragment was also increased in CD (80.0%) compared with controls (35.0%, pc = 5.6 X 10(-3)). It is reasonable to infer that the DRw53 is the most important susceptibility antigen in Japanese CD. The subtypes of the DR4 were determined by the hybridization of the DQ-B probe. The DQ-B PstI fragment patterns were not different in CD and controls.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2322470

Source DB:  PubMed          Journal:  Exp Clin Immunogenet        ISSN: 0254-9670


  9 in total

1.  HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis.

Authors:  P C Stokkers; P H Reitsma; G N Tytgat; S J van Deventer
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

2.  Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studies.

Authors:  Bing Xia; JBA Crusius; SGM Meuwissen; AS Pe?a
Journal:  World J Gastroenterol       Date:  1998-10       Impact factor: 5.742

3.  An HLA study on 149 Japanese patients with Crohn's disease.

Authors:  H Matake; N Okabe; S Naito; T Yao
Journal:  Gastroenterol Jpn       Date:  1992-08

4.  HLA class II genes in primary sclerosing cholangitis and chronic inflammatory bowel disease: no HLA-DRw52a association in Swedish patients with sclerosing cholangitis.

Authors:  H Zetterquist; U Broomé; K Einarsson; O Olerup
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

5.  Analysis of the contribution of HLA genes to genetic predisposition in inflammatory bowel disease.

Authors:  I Naom; J Lee; D Ford; S J Bowman; J S Lanchbury; I Haris; S V Hodgson; D Easton; J Lennard-Jones; C G Mathew
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

6.  Crohn's disease: the genetic contribution.

Authors:  J Sofaer
Journal:  Gut       Date:  1993-07       Impact factor: 23.059

7.  Linkage of Crohn's disease to the major histocompatibility complex region is detected by multiple non-parametric analyses.

Authors:  H Yang; S E Plevy; K Taylor; D Tyan; N Fischel-Ghodsian; C McElree; S R Targan; J I Rotter
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

8.  T cell cytotoxicity of autologous and allogeneic lymphocytes in a patient with Crohn's disease.

Authors:  K Okazaki; Y Yokoyama; Y Yamamoto; M Kobayashi; K Araki; T Ogata
Journal:  J Gastroenterol       Date:  1994-08       Impact factor: 7.527

9.  Polymorphisms of FCRL3 in a Chinese population with Vogt-Koyanagi-Harada (VKH) syndrome.

Authors:  Ke Li; Peizeng Yang; Min Zhao; Shengping Hou; Liping Du; Hongyan Zhou; Aize Kijlstra
Journal:  Mol Vis       Date:  2009-05-11       Impact factor: 2.367

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.